Heart Disease Clinical Trials

Showing 4081-4100 of 7,313 trials

Ten-Year Outcomes of PRE-COMBAT Trial

NCT03871127

This study evaluates Ten-Year Outcomes of PREmier of Randomized Comparison of Sirolimus-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Artery Stenosis(PRECOMBAT trial).

Coronary Artery Disease

Seung-Jung Park600 participantsStarted May 2019

Gwangju, South Korea • Seongnam, South Korea • Seoul, South Korea +6 more locations

COMPLETEDNA

Effect of Wine Consumption on Cardiovascular Markers in CHDs Patients

NCT04438122

Many epidemiological studies support that 20-30gr of alcohol consumption per day is related with lower risk for cardiovascular diseases, heart attack as well as mortality related to these diseases. Since the French paradox was reported, a number of experimental and clinical studies have demonstrated the protective effect of red wine compared to other alcoholic drinks on different pathways of the pathogenesis of atherosclerosis. The investigator's previous results revealed that wine contain micro-constituents that exert potent in vitro anti-platelet and anti-inflammatory actions. Also, the wine consumption along with a standardized meal reduced platelet aggregation and biosynthesis of Platelet Activating Factor in healthy men. Although a large number of studies have reported protective effect of wine against atherosclerosis in healthy people there are few data about the effect of long-term moderate wine consumption in population with CVD. Therefore, the aim of this randomized, intervention clinical study, with control group was to report the effects of regular light to moderate wine consumption on cardiovascular biomarkers in people with CVD.

Cardiovascular Disease

Harokopio University57 participantsStarted Sep 2013

Athens, Greece

Ten-Year Outcomes of PRE-COMBAT Trial

Effect of Wine Consumption on Cardiovascular Markers in CHDs Patients

Related Searches

Viral Illness in Pediatric Critical Care: Incidence Timing & Severity of Associated Heart Dysfunction & Acute Kidney Injury

An Innovative Disease-net Management Model for Non-communicable Diseases (SIDERA^B)

Self-Management App for Patients With Left-Ventricular Assist Devices

Thrombogenicity Assessment in Patients Treated With Bioresorbable Vascular Scaffolds

Artimes Pro Low Profile Dilatation Catheters for Pre-Dilatation in Patients With Symptomatic Ischemic Heart Disease

Preemptive Lung Impedance-guided Therapy of Evolving Acute Heart Failure in Acute Myocardial Infarction Patients

Clinical Study on the Effect of Zhenyuan Capsule on Cardiopulmonary Function in Patients With SCAD

Effects of Preferential Left Ventricular Pacing on Ventriculoarterial Coupling and Clinical Course of Heart Failure

Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation

PROgnostic Value of Exercise Capacity Measured as Peak Oxygen Uptake (pVO2) in Recipients of Left Ventricular Assist Devices

Cardiovascular Complications of Carfilzomib

TXT2HEART COLOMBIA: Evaluation of the Efficacy and Safety of Text Messages to Improve Adherence to Cardiovascular Medications in Secondary Prevention

TMAO in Patients With Severe Aortic Stenosis

Scandinavian Multicenter Study to Advance Risk Stratification in Heart Disease- Ventricular Arrhythmias

A Supportive Care Programme for People With Heart Failure

Spontaneous Coronary Artery Dissection Registry (DIssezioni Spontanee COronariche ITalian-SPAnish)

Effects of Exercise Training on Fluid Instability in Heart Failure Patients

Comparison of MECHANISM of Early and Late Vascular Responses Following Treatment of ST-elevation Acute Myocardial Infarction With Two Different Everolimus-eluting Stents: Randomized Controlled Trial Between Biodegradable Polymer and Durable Polymer Stent (MECHANISM-AMI-RCT)